Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.

NCT00214552 is registered in ClinicalTrials.gov with Associated Scientists to Help Minimize Allergies as lead sponsor.

NCT NCT00214552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
Lead sponsor
Associated Scientists to Help Minimize Allergies
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2002
Completion date
March 31, 2005
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, gastroesophageal reflux disease